Found 49 matching trials
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
PHASE3The purpose of this observer blind study is to assess the safety in terms o...
Location
GSK Investigational Site
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
PHASE3In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgam...
Location
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Kamalapur Field office, Lichubagan Rd
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
PHASE3This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Location
GSK Investigational Site
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
PHASE3The purpose of this study is to document the immunological response to the ...
Location
Multiple Locations
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
PHASE3This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Location
GSK Investigational Site
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules
PHASE4This is a phase IV open-label randomized clinical trial that will compare i...
Location
Mirpur Clinic (International Centre for Diarrhoeal Disease Research, Bangladesh)
A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
PHASE3The study will compare the transmissible levels of poliovirus type-2 detect...
Location
icddr,b - Matlab Health Research Centre
3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants
PHASE2The background of the present clinical trial is the overall aim of the Worl...
Location
Hospital Maternidad Nuestra de la Altagracia
Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules
PHASE3In this study, infants who were previously vaccinated with hepatitis B vacc...
Location
GSK Investigational Site
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months
PHASE3The trial is a phase III, non-inferiority, observer-blind, randomised, cont...
Location
5 sites in Philippines